{"transactions":[{"id":739873,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:06:59.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":10891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":10891,"derivative":{"exercise_price":23.42,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":10891},"source":{"system":"sec-edgar","filing":"0001628280-26-043003","document":"wk-form4_1781312816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000162828026043003/wk-form4_1781312816.xml","form_type":"4"}},{"id":739872,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:06:59.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":6405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":26541,"source":{"system":"sec-edgar","filing":"0001628280-26-043003","document":"wk-form4_1781312816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000162828026043003/wk-form4_1781312816.xml","form_type":"4"}},{"id":833530,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-19T17:43:00.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":500,"price":21.81,"value":10905.0,"ownership":{"direct":true},"balance_after":20136,"source":{"system":"sec-edgar","filing":"0001628280-26-019890","document":"wk-form4_1773956578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000162828026019890/wk-form4_1773956578.xml","form_type":"4"}},{"id":1111740,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T16:18:16.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":11279,"derivative":{"exercise_price":24.34,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":11279},"source":{"system":"sec-edgar","filing":"0001396814-25-000085","document":"wk-form4_1749845889.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000139681425000085/wk-form4_1749845889.xml","form_type":"4"}},{"id":1111739,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T16:18:16.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":20636,"source":{"system":"sec-edgar","filing":"0001396814-25-000085","document":"wk-form4_1749845889.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000139681425000085/wk-form4_1749845889.xml","form_type":"4"}},{"id":1436017,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-12T20:33:26.000Z","date":"2024-08-12","kind":"purchase","planned":false,"acquired":true,"shares":1400,"price":11.58,"value":16212.0,"ownership":{"direct":true},"balance_after":14473,"source":{"system":"sec-edgar","filing":"0001396814-24-000107","document":"wk-form4_1723509201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000139681424000107/wk-form4_1723509201.xml","form_type":"4"}},{"id":1480773,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T18:13:25.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":12179,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12179,"derivative":{"exercise_price":28.68,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":12179},"source":{"system":"sec-edgar","filing":"0001396814-24-000077","document":"wk-form4_1718316798.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000139681424000077/wk-form4_1718316798.xml","form_type":"4"}},{"id":1480772,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T18:13:25.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":5230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":13073,"source":{"system":"sec-edgar","filing":"0001396814-24-000077","document":"wk-form4_1718316798.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000139681424000077/wk-form4_1718316798.xml","form_type":"4"}},{"id":1852356,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T17:30:17.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12925,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12925,"derivative":{"exercise_price":38.74,"exercise_date":"2024-06-14","expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":12925},"source":{"system":"sec-edgar","filing":"0001209191-23-038020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919123038020/doc4.xml","form_type":"4"}},{"id":1852355,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T17:30:17.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2024, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":7843,"source":{"system":"sec-edgar","filing":"0001209191-23-038020","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919123038020/doc4.xml","form_type":"4"}},{"id":2239167,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T19:22:55.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":8225,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8225,"derivative":{"exercise_price":59.39,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":8225},"source":{"system":"sec-edgar","filing":"0001209191-22-035218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919122035218/doc4.xml","form_type":"4"}},{"id":2239166,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-08T19:22:55.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":1160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":6068,"source":{"system":"sec-edgar","filing":"0001209191-22-035218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919122035218/doc4.xml","form_type":"4"}},{"id":2274815,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T16:13:27.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":1000,"price":59.37,"value":59370.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.36 to $59.41, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4908,"source":{"system":"sec-edgar","filing":"0001209191-22-028275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919122028275/doc4.xml","form_type":"4"}},{"id":2463941,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-20T16:13:58.000Z","date":"2021-12-17","kind":"gift","acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5908,"source":{"system":"sec-edgar","filing":"0001209191-21-070553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919121070553/doc4.xml","form_type":"4"}},{"id":2672085,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T20:32:09.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":7626,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7626,"derivative":{"exercise_price":60.96,"exercise_date":"2022-06-09","expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":7626},"source":{"system":"sec-edgar","filing":"0001209191-21-040082","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919121040082/doc4.xml","form_type":"4"}},{"id":2672084,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T20:32:09.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":1066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":6308,"source":{"system":"sec-edgar","filing":"0001209191-21-040082","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919121040082/doc4.xml","form_type":"4"}},{"id":2782756,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T20:01:14.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":734,"price":72.26,"value":53038.84,"ownership":{"direct":true},"balance_after":5242,"source":{"system":"sec-edgar","filing":"0001209191-21-021583","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919121021583/doc4.xml","form_type":"4"}},{"id":3113461,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T18:23:14.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":8027,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8027,"derivative":{"exercise_price":47.65,"exercise_date":"2021-06-09","expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":8027},"source":{"system":"sec-edgar","filing":"0001209191-20-036036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919120036036/doc4.xml","form_type":"4"}},{"id":3113460,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-11T18:23:14.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":1260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2021, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":5976,"source":{"system":"sec-edgar","filing":"0001209191-20-036036","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919120036036/doc4.xml","form_type":"4"}},{"id":3335209,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-19T16:14:49.000Z","date":"2019-12-16","kind":"gift","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4716,"source":{"system":"sec-edgar","filing":"0001209191-19-061298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919119061298/doc4.xml","form_type":"4"}},{"id":3499097,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T16:30:21.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":8437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":8437,"derivative":{"exercise_price":43.54,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":8437},"source":{"system":"sec-edgar","filing":"0001209191-19-035074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919119035074/doc4.xml","form_type":"4"}},{"id":3499096,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T16:30:21.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":4134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2020, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":5016,"source":{"system":"sec-edgar","filing":"0001209191-19-035074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919119035074/doc4.xml","form_type":"4"}},{"id":3892690,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T19:13:07.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":4693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":4693,"derivative":{"exercise_price":38.35,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":4693},"source":{"system":"sec-edgar","filing":"0001209191-18-038190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919118038190/doc4.xml","form_type":"4"}},{"id":3892689,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T19:13:07.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2019, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":882,"source":{"system":"sec-edgar","filing":"0001209191-18-038190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919118038190/doc4.xml","form_type":"4"}},{"id":4232623,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-16T20:43:32.000Z","date":"2017-08-08","kind":"purchase","acquired":true,"shares":100,"price":37.1316,"value":3713.16,"ownership":{"direct":true},"balance_after":100,"source":{"system":"sec-edgar","filing":"0001209191-17-049323","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919117049323/doc4.xml","form_type":"4"}},{"id":4279280,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":38745,"kind":"person","name":"Froimson Mark","position":1,"cik":"0001709050","reported_name":"Froimson Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-16T20:12:55.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":8144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 36 equal successive monthly installments over the 36-month period following the date of grant, subject to the reporting person's continued service as a director."}],"balance_after":8144,"derivative":{"exercise_price":44.2,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":8144},"source":{"system":"sec-edgar","filing":"0001209191-17-040688","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709050/000120919117040688/doc4.xml","form_type":"4"}}]}